176 related articles for article (PubMed ID: 31074257)
1. Assessment of Copper Nanoclusters for Accurate in Vivo Tumor Imaging and Potential for Translation.
Heo GS; Zhao Y; Sultan D; Zhang X; Detering L; Luehmann HP; Zhang X; Li R; Choksi A; Sharp S; Levingston S; Primeau T; Reichert DE; Sun G; Razani B; Li S; Weilbaecher KN; Dehdashti F; Wooley KL; Liu Y
ACS Appl Mater Interfaces; 2019 Jun; 11(22):19669-19678. PubMed ID: 31074257
[TBL] [Abstract][Full Text] [Related]
2. Gold Nanoclusters Doped with (64)Cu for CXCR4 Positron Emission Tomography Imaging of Breast Cancer and Metastasis.
Zhao Y; Detering L; Sultan D; Cooper ML; You M; Cho S; Meier SL; Luehmann H; Sun G; Rettig M; Dehdashti F; Wooley KL; DiPersio JF; Liu Y
ACS Nano; 2016 Jun; 10(6):5959-70. PubMed ID: 27159079
[TBL] [Abstract][Full Text] [Related]
3. Integrin αvβ3-Targeted [
Cui L; Xiong C; Zhou M; Shi S; Chow DS; Li C
Bioconjug Chem; 2018 Dec; 29(12):4062-4071. PubMed ID: 30404438
[TBL] [Abstract][Full Text] [Related]
4. Ultrasmall [(64)Cu]Cu nanoclusters for targeting orthotopic lung tumors using accurate positron emission tomography imaging.
Gao F; Cai P; Yang W; Xue J; Gao L; Liu R; Wang Y; Zhao Y; He X; Zhao L; Huang G; Wu F; Zhao Y; Chai Z; Gao X
ACS Nano; 2015 May; 9(5):4976-86. PubMed ID: 25919205
[TBL] [Abstract][Full Text] [Related]
5. Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances.
Miller-Kleinhenz JM; Bozeman EN; Yang L
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(6):797-816. PubMed ID: 25966677
[TBL] [Abstract][Full Text] [Related]
6. CC Chemokine Receptor 2-Targeting Copper Nanoparticles for Positron Emission Tomography-Guided Delivery of Gemcitabine for Pancreatic Ductal Adenocarcinoma.
Zhang X; Detering L; Sultan D; Luehmann H; Li L; Heo GS; Zhang X; Lou L; Grierson PM; Greco S; Ruzinova M; Laforest R; Dehdashti F; Lim KH; Liu Y
ACS Nano; 2021 Jan; 15(1):1186-1198. PubMed ID: 33406361
[TBL] [Abstract][Full Text] [Related]
7. Copper-64-alloyed gold nanoparticles for cancer imaging: improved radiolabel stability and diagnostic accuracy.
Zhao Y; Sultan D; Detering L; Cho S; Sun G; Pierce R; Wooley KL; Liu Y
Angew Chem Int Ed Engl; 2014 Jan; 53(1):156-9. PubMed ID: 24272951
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Targeted Nanoparticle Assemblies for Atherosclerosis Imaging with Positron Emission Tomography and Potential for Clinical Translation.
Liu Y; Luehmann HP; Detering L; Pressly ED; McGrath AJ; Sultan D; Nguyen A; Grathwohl S; Shokeen M; Zayed M; Gropler RJ; Abendschein D; Hawker CJ; Woodard PK
ACS Appl Mater Interfaces; 2019 May; 11(17):15316-15321. PubMed ID: 30969098
[TBL] [Abstract][Full Text] [Related]
9. Facile synthesis, pharmacokinetic and systemic clearance evaluation, and positron emission tomography cancer imaging of ⁶⁴Cu-Au alloy nanoclusters.
Zhao Y; Sultan D; Detering L; Luehmann H; Liu Y
Nanoscale; 2014 Nov; 6(22):13501-9. PubMed ID: 25266128
[TBL] [Abstract][Full Text] [Related]
10. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
Ni D; Jiang D; Ehlerding EB; Huang P; Cai W
Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335
[TBL] [Abstract][Full Text] [Related]
11. Renal-Clearable Ultrasmall Coordination Polymer Nanodots for Chelator-Free
Shen S; Jiang D; Cheng L; Chao Y; Nie K; Dong Z; Kutyreff CJ; Engle JW; Huang P; Cai W; Liu Z
ACS Nano; 2017 Sep; 11(9):9103-9111. PubMed ID: 28853861
[TBL] [Abstract][Full Text] [Related]
12. Chelator-Free Radiolabeling of Nanographene: Breaking the Stereotype of Chelation.
Shi S; Xu C; Yang K; Goel S; Valdovinos HF; Luo H; Ehlerding EB; England CG; Cheng L; Chen F; Nickles RJ; Liu Z; Cai W
Angew Chem Int Ed Engl; 2017 Mar; 56(11):2889-2892. PubMed ID: 28170126
[TBL] [Abstract][Full Text] [Related]
13. A positron emission tomography image-guidable unimolecular micelle nanoplatform for cancer theranostic applications.
Yang J; Lu W; Xiao J; Zong Q; Xu H; Yin Y; Hong H; Xu W
Acta Biomater; 2018 Oct; 79():306-316. PubMed ID: 30172067
[TBL] [Abstract][Full Text] [Related]
14. LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging of Triple Negative Breast Cancer.
Abulrob A; Corluka S; Blasiak B; Gino Fallone B; Ponjevic D; Matyas J; Tomanek B
Mol Imaging Biol; 2018 Jun; 20(3):428-435. PubMed ID: 29101636
[TBL] [Abstract][Full Text] [Related]
15. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
Brinkman AM; Chen G; Wang Y; Hedman CJ; Sherer NM; Havighurst TC; Gong S; Xu W
Biomaterials; 2016 Sep; 101():20-31. PubMed ID: 27267625
[TBL] [Abstract][Full Text] [Related]
16. CuS Nanodots with Ultrahigh Efficient Renal Clearance for Positron Emission Tomography Imaging and Image-Guided Photothermal Therapy.
Zhou M; Li J; Liang S; Sood AK; Liang D; Li C
ACS Nano; 2015 Jul; 9(7):7085-96. PubMed ID: 26098195
[TBL] [Abstract][Full Text] [Related]
17. ImmunoPET of tissue factor expression in triple-negative breast cancer with a radiolabeled antibody Fab fragment.
Shi S; Hong H; Orbay H; Graves SA; Yang Y; Ohman JD; Liu B; Nickles RJ; Wong HC; Cai W
Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1295-303. PubMed ID: 25801992
[TBL] [Abstract][Full Text] [Related]
18. C-X-C Chemokine Receptor Type 4-Targeted Imaging in Glioblastoma Multiforme Using
Zhang X; Detering L; Sultan D; Heo GS; Luehmann H; Taylor S; Choksi A; Rubin JB; Liu Y
ACS Appl Bio Mater; 2022 Jan; 5(1):235-242. PubMed ID: 35014818
[TBL] [Abstract][Full Text] [Related]
19. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
20. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
Carlos Dos Santos J; Beijer B; Bauder-Wüst U; Schäfer M; Leotta K; Eder M; Benešová M; Kleist C; Giesel F; Kratochwil C; Kopka K; Haberkorn U; Mier W
J Nucl Med; 2020 Jan; 61(1):70-79. PubMed ID: 31541034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
